SCHEMBL11299779

SCHEMBL11299779

CN(C(=O)O)c1c(I)ccc2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NCEH1 Q6PIU2 7/20 0.44
WDR5 P61964 1/20 0.40
SIGMAR1 Q99720 1/20 0.39
LDHA P00338 1/20 0.39
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
USP2 O75604 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
NR4A1 P22736 1/20 0.38
NR4A2 P43354 1/20 0.38
NR4A3 Q92570 1/20 0.38
LMNA P02545 1/20 0.38
GRIN2D O15399 1/20 0.37
GRIN2A Q12879 1/20 0.37
GRIN2C Q14957 1/20 0.37
CFTR P13569 1/20 0.37
AKR1B1 P15121 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6249497 0.81 PTPN1 (0.50) LDHAKMT2AMEN1USP2ALDH1A1
SCHEMBL1695233 0.79 ALDH1A1 (0.52) SIGMAR1KMT2AMEN1ALDH1A1HPGD
SCHEMBL9296111 0.78 CYP2A6 (0.44) NCEH1SIGMAR1KMT2AMEN1ALDH1A1
SCHEMBL1614544 0.72 SIGMAR1 (0.67) SIGMAR1NR4A1NR4A2NR4A3
SCHEMBL29666490 0.72 SIGMAR1 (0.67) SIGMAR1NR4A1NR4A2NR4A3
SCHEMBL3370074 0.69 HSD17B10 (0.59) WDR5LDHAKMT2AMEN1USP2
SCHEMBL29223852 0.69 WDR5 (0.59) NCEH1WDR5LDHAALDH1A1HPGD
SCHEMBL4748549 0.69 CYP2A6 (0.38) NCEH1SIGMAR1ALDH1A1HSD17B10LMNA
SCHEMBL4124403 0.68 NCEH1 (0.55) NCEH1WDR5KMT2AMEN1ALDH1A1
SCHEMBL5245193 0.68 KDM4E (0.46) NCEH1KMT2AMEN1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0055857-A2 Potentiation of topical compositions UNION CARBIDE CORPORATION (US) 1982-07-14 EP claimed
US-20200102281-A1 FREE RADICAL- AND REACTIVE OXYGEN SPECIES-REACTING COMPOUNDS DUKE CHRISTOPHER (US) 2020-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200102281-A1 FREE RADICAL- AND REACTIVE OXYGEN SPECIES-REACTING COMPOUNDS ROS1, NOX4, GPX4 NCEH1 2673/4885WDR5 3627/4885SIGMAR1 1670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.